T he distal gut of mammals harbours complex and dynamic microbial communities that are shaped by diet and host factors. These communities provide the host with a vast range of functions such as digestion of complex dietary components (for example, plant polysaccharides), production of vitamins, maturation of the immune system and regulation of host metabolism 1 . Dietary components that are not absorbed in the proximal intestine reach the distal gut, where they are metabolized through processes that involve trophic interactions among members of the microbial community 2 . Diets rich in plant polysaccharides accessible to microbes boost the growth of many intestinal bacteria, which have evolved complex mechanisms to efficiently break down and metabolize these substrates 3-6 . Consequently, relative to low-fibre diets, consumption of diets enriched in carbohydrates accessible to gut microbes is associated with increased bacterial diversity 7,8 .
atherosclerosis (apolipoprotein E-deficient (ApoE −/− ) mice) develop smaller atherosclerotic lesions compared to colonized counterparts 12 ; Toll-like receptors and nucleotide-binding oligomerization domain-like receptors, which recognize bacterial proinflammatory molecules, have been implicated in the development of atherosclerosis 13 ; and trimethylamine-N-oxide, a host-synthesized derivative of the bacterial metabolite trimethylamine, both enhances atherosclerosis in animal models and is associated with cardiovascular risks in humans 14, 15 . Furthermore, patients with symptomatic atherosclerotic plaques contain lower levels of gut bacteria predicted to generate butyrate 16 .
Most human gut-associated butyrate producers are Firmicutes, with the majority belonging to clostridial clusters XIVa and IV. The most common isolates include species related to Roseburia spp. and Eubacterium rectale within cluster XIVa and Faecalibacterium prausnitzii within cluster IV 17 . Recent studies indicate that patients with type 2 diabetes harbour lower levels of these taxa 18, 19 . Moreover, butyrate-producing bacteria are highly responsive to host diet: for example, faecal levels of R. intestinalis were higher in subjects consuming resistant starch-enriched diets compared to those consuming diets low in total carbohydrate 20, 21 .
Despite the evidence suggesting that butyrate has anti-inflammatory effects and correlation studies that demonstrate increased levels of butyrate-producing bacteria in healthy individuals compared to those with cardiometabolic disease 16, 18, 19 , the impact of this important group of organisms on host health has not been experimentally verified. Specifically, it is not known whether butyrate-producing bacteria alter susceptibility and progression of atherosclerosis. In this study we show that colonization with R. intestinalis decreases levels of inflammatory markers and atherosclerosis in a diet-dependent manner, and demonstrate that the end product of bacterial metabolism, butyrate, mediates these effects.
Results
Abundance of Roseburia sp. is inversely correlated with atherosclerotic lesion size in a genetically diverse mouse cohort. We examined the bacterial communities in the caeca from 83 strains of mice derived from the Hybrid Mouse Diversity Panel (HMDP) 22 . These strains were made susceptible to atherosclerosis by transgenic expression of human apolipoprotein E3-Leiden and human cholesteryl ester transfer protein. Characterization of 342 F 1 mice expressing both transgenes (Ath-HMDP) exposed to a high-fat cholesterol diet for 16 weeks showed a wide range in size of atherosclerotic lesions across the different strains 22 . We performed 16S ribosomal RNA gene sequencing of faecal DNA from these animals and conducted correlation analysis to identify taxa associated with atherosclerotic plaque size (Supplementary Table 1 ). We identified a number of genera whose abundances were associated (P < 0.05) with plaque size ( Supplementary Fig. 1 and Supplementary Table 2 ). Among them Roseburia (P = 0.0035, bicor = − 0.157) showed the strongest negative correlation. This is consistent with human studies 16 and suggests that butyrateproducing bacteria may inhibit development of atherosclerosis. Although total plasma cholesterol levels showed a strong positive correlation with plaque size in these mice ( Supplementary Fig. 2a ), the relative abundance of Roseburia was not correlated with cholesterol ( Supplementary Fig. 2b ), implying that butyrate-producing bacteria may not affect cholesterol homeostasis.
Colonization with R. intestinalis modulates caecal butyrate accumulation in gnotobiotic mice fed a diet with high content of plant polysaccharides (HPP). GF mice, inoculated with specific microbes isolated from the human gut, were used to study the role of butyrate-producing bacteria in vivo. Two groups of 8-week-old GF male ApoE −/− mice were orally gavaged with the following microbial mixtures: a 'core' community that included eight species that are commonly found in the human microbiota with a limited capacity to produce butyrate (Anaerotruncus colihominis, Bacteroides caccae, Bacteroides thetaiotaomicron, Clostridium symbiosum, Collinsella aerofaciens, Coprococcus comes, Providencia stuartii and Ruminococcus torques); or the same 'core' community plus R. intestinalis (Supplementary Table 3 ). All mice were fed a standard HPP chow diet (Fig. 1a) , and successful transplantation of these communities was confirmed using community profiling by sequencing (COPRO-Seq) analysis (Fig. 1b) . The most significant difference in the communities was the presence of R. intestinalis, which represented 25.1% of the faecal 'core plus R. intestinalis' community. C. aerofaciens was disproportionally impacted by R. intestinalis, showing an approximately fourfold decrease in the presence of the butyrate producer compared to core communitycolonized mice ( Fig. 1b and Supplementary Table 4 ). These effects were observed even when R. intestinalis was not considered as part of the community for the calculations (that is, core species considered as 100% for both groups; Supplementary Fig. 3 and Supplementary  Table 5 ). Moreover, C. comes and C. symbiosum also showed lower relative abundance in the presence of R. intestinalis ( Fig. 1b and Supplementary Table 4 ); however, these differences disappear when R. intestinalis is not considered for the calculations (Supplementary Fig. 3 and Supplementary Table 5 ).
Mice were euthanized 18 weeks after colonization, and plasma and caecal contents were collected for biochemical analyses. Colonization with the 'core plus R. intestinalis' community resulted in a fourfold increase of caecal butyrate levels compared with the 'core' community ( Fig. 1c and Supplementary Fig. 4 ). We also observed a significant reduction of caecal acetate levels-a substrate used by some butyrate-producing bacteria including R. intestinalis for butyrate production 23 . Nonetheless, plasma levels of butyrate and acetate were not significantly different between these two groups of mice ( Fig. 1d ), suggesting rapid metabolism of butyrate in peripheral tissues such as the intestine and the liver 24 . These results demonstrate that gut microbial composition affects caecal SCFA levels, and that colonization with R. intestinalis increases caecal butyrate concentration in mice fed the HPP diet.
Colonization with R. intestinalis inhibits the development of atherosclerotic plaque formation in gnotobiotic mice fed the HPP diet. By a variety of measures the HPP-fed 'core' and 'core plus R. intestinalis' colonized mice were indistinguishable. For example, colonization with R. intestinalis did not affect plasma or liver lipid profiles ( Supplementary Fig. 5a and Supplementary Table 6 ). In contrast, evaluation of atherosclerotic lesions of the aortic sinus showed marked differences: mice colonized with R. intestinalis exhibited a 30% reduction of atherosclerotic lesion development compared to mice colonized with the 'core' community (aortic sinus mean plaque area; 23.8 ± 1.7 × 10 4 μ m 2 in 'core' ApoE −/− mice, 16.7 ± 1.7 × 10 4 μ m 2 in 'core plus R. intestinalis' ApoE −/− mice; Fig. 2a ,e). Remarkably, there was a significant negative correlation between caecal levels of butyrate and lesion size ( Supplementary Fig. 5b ). In contrast, plasma cholesterol levels were not associated with lesion size ( Supplementary Fig. 5c ).
Lipid deposition measured with Oil Red O-stained sections showed that mice colonized with R. intestinalis also had a reduced lipid area ( Fig. 2a,f ). Immunohistochemical studies of atherosclerotic lesions showed that mice colonized with the 'core plus R. intestinalis' community developed atherosclerotic lesions that exhibited a lower number of macrophages ( Fig. 2b,g ) and increased levels of collagen ( Fig. 2c,h ), suggesting that colonization with R. intestinalis promoted the stability of atherosclerotic plaques. In contrast, levels of smooth muscle cells in the aortic sinus were not affected by microbial community composition ( Fig. 2d ,i). To further define possible R. intestinalis-perturbed host factors associated with reduced atherosclerotic lesions and macrophage infiltration in the aortic root, we examined messenger RNA levels of several inflammatory markers of atherosclerosis in the aorta. While there were no significant differences in the mRNA levels of Il (interleukin)-6, Il-1β, Mcp1 (monocyte chemoattractant protein 1) and Icam1 (intracellular adhesion molecule 1), we detected a marked reduction in the relative mRNA levels of tumour necrosis factor α (Tnf-α) and vascular cell adhesion molecule 1 (Vcam1) associated with the presence of R. intestinalis (Fig. 2j ). Both TNF-α and VCAM-1 have a central role in controlling inflammatory processes and atherosclerosis development independent of plasma cholesterol levels 25, 26 . These results suggest that colonization with R. intestinalis modulates atherosclerosis by reducing aortic inflammation.
We next tested whether the athero-protective effect of R. intestinalis is modulated by diet. GF male ApoE −/− mice colonized with the same communities described above were fed a diet low in complex plant polysaccharides (LPP diet, Supplementary Fig. 6a ). In contrast to the HPP-fed animals, in LPP-fed animals R. intestinalis represented only 0.3% of the faecal 'core plus R. intestinalis' community ( Supplementary Fig. 6b ,c and Supplementary Table 7 ). Under this condition, R. intestinalis did not impact community composition or any measurement collected at the time of euthanasia, including SCFA levels and atherosclerotic lesions (Supplementary  Figs. 7 and 8 and Supplementary Table 6 ). Thus, the abundance and athero-protective effects of R. intestinalis depend on the availability of dietary plant polysaccharides.
R. intestinalis modulates intestinal epigenetic programming in the colon of mice fed the HPP diet.
Mice colonized with R. intestinalis that were fed the HPP diet showed increased butyrate levels in the intestinal contents but not in plasma. As mentioned above, butyrate is a HDAC inhibitor; increased histone acetylation is generally associated with open chromatin and active transcription. Histone acetylation has also been shown to positively correlate with histone methylation in vitro 27 , and the effects of histone methylation are more complex and depend on both the site and degree of methylation. Moreover, histone post-translational modification (PTM) states are combinatorial and are thought to integrate cellular signals by sensing changes in the environment (namely via metabolite availability), ultimately mediating adaptive transcriptional responses 28 .
We hypothesized that the effects of butyrate-producing bacteria on atherosclerosis may be mediated by changes that originate in the gut. To assess whether the presence of R. intestinalis impacted epigenetic programming in the colon or aorta in mice fed both diets, we surveyed > 50 unique and combinatorial acetylated and methylated histone PTM states in proximal colon and aorta samples using a label-free data-independent acquisition mass spectrometry workflow ( Supplementary Table 8 ) 29 . Principal component analysis of chromatin signatures reveals that R. intestinalis has a more pronounced effect on epigenetic programming in mice fed the HPP diet compared to animals fed the LPP diet ( Supplementary  Fig. 9 ). Although no changes were observed on histone H4, both acetylation and methylation of histone H3 and the variant histone H3.3, which is typically found in areas of active transcription, were affected by R. intestinalis ( Fig. 3a-e ). The majority of chromatin state changes induced by R. intestinalis in mice fed the HPP diet are indicative of active transcription. This includes increased abundance of highly methylated forms of Lys 36 on histone H3 and H3.3 and the coeluting, isobaric peptides containing K18ac/ K23ac, all of which are associated with activation of transcription or transcriptional elongation ( Fig. 3b-d) . These increases were accompanied by a significant decrease in peptides containing monomethylated and unmodified Lys 36, suggesting a global shift toward more highly methylated forms of Lys 36. Consistent with the very low colonization by R. intestinalis, these PTM states remained unchanged in the LPP-fed mice colonized with the 'core plus R. intestinalis' community ( Fig. 3b-d ). Methylation of H3K4 and H3K79 is also associated with transcriptional activation. R. intestinalis induced an increase in K4me1 and K79me1, but a decrease in K4me3 and K79me2 in proximal colon of mice fed the HPP diet ( Fig. 3a,e ). Unexpectedly, there was a significant increase in K4me3 in response to R. intestinalis in mice fed the LPP diet ( Fig. 3a) . These data suggest that diet-microbiota interactions differentially regulate both histone methylation and acetylation in the intestine in response to R. intestinalis. In contrast, the presence of R. intestinalis did not elicit robust PTM changes in the aortae from mice fed both diets (Supplementary Fig. 10 and Supplementary  Table 9 ). Together, these results suggest that the presence of this butyrate-producing organism may alter susceptibility to atherosclerosis by affecting gene expression in the distal gut.
R. intestinalis regulates energy metabolism and reduces endotoxaemia in mice fed the HPP diet.
To assess whether R. intestinalisassociated changes in colonic chromatin states affect gene expression, we performed RNA-seq analysis of colon tissues of HPP-fed mice. A total of 101 genes were differentially expressed between these two groups (false discovery rate (FDR) < 0.05; Supplementary Table 10 ). Gene Ontology database terms for processes such as monocarboxylic acid metabolism, small-molecule metabolism and fatty acid metabolism were enriched among the genes that were significantly (P < 0.05) upregulated in colons from 'core plus R. intestinalis' mice compared to those from 'core' controls ( Fig. 4a ). Specifically, there was a significant increase in the expression of genes associated with fatty acid oxidation such as Acox1 (acyl-CoA oxidase 1), Acsf2 (acyl-CoA synthetase family member 2) and Decr2 (2,4- immunity and inflammation such as leukocyte differentiation and TGFβ (transforming growth factor beta) receptor signalling pathway were enriched among the genes downregulated in the colons from mice colonized with the 'core plus R. intestinalis' community ( Fig. 4b ). Together, these results suggest that colonization with R. intestinalis switches the enterocyte energy substrate from glucose to butyrate, which is in agreement with a previous report showing that butyrate regulates energy metabolism in colonocytes 30 . and Vcam1 in the aorta from mice colonized with the 'core' community (n = 6) or the 'core plus R. intestinalis' community (n = 5). The data are expressed as box-and-whisker plots, where the boxes indicate the median values and the interquartile ranges and the whiskers represent the minimum and maximum values. Significance was calculated by an unpaired two-tailed Student's t-test, followed by the Benjamini-Hochberg procedure to control the FDR. Gene expression of Tnf-α and Vcam1 showed statistical significance (q value of < 0.10).
Elegant studies have shown that the metabolic effects elicited by butyrate on intestinal epithelial cells enhance barrier function and decrease intestinal permeability 31 . Thus, we tested whether colonization with R. intestinalis impacted gut paracellular permeability in vivo using the fluorescein isothiocyanate (FITC)-dextran assay. We found that colonization with R. intestinalis decreased intestinal permeability, yet the difference did not reach significance (Fig. 4c ), and resulted in significantly lower levels of plasma lipopolysaccharide (LPS; Fig. 4d ). Consistent with this observation, we detected upregulation of tight junction genes such as Cldn3 (claudin3) and Cldn4 in mice colonized with R. intestinalis (Supplementary Fig. 11 and Supplementary Table 11 ). Collectively, our results suggest that R. intestinalis improves intestinal barrier function and reduces the amount of endotoxin in the bloodstream. Consistent with these findings, colonization with R. intestinalis resulted in a marked reduction of pro-inflammatory gene expression in the aorta (Fig. 2j ). Furthermore, plasma levels of IL-12p40 were significantly decreased in mice colonized with R. intestinalis ( Supplementary  Fig. 12 ), which might be attributed to the reduction in aortic inflammatory molecules such as TNF-α and VCAM1 ( Fig. 2j ).
Butyrate has also been found to induce the differentiation of regulatory T cells (Tregs) 32 ; however, flow cytometric analysis detected no differences in CD4 + T cells and Tregs in spleen or para-aortic lymph node samples between mice colonized with the two different communities ( Supplementary Fig. 13a -c). We also investigated the effects of R. intestinalis gut colonization on T-cell/Treg-associated molecules and found no changes in the expression of Cd4, Ifnγ (interferon γ ), Il-10 and Foxp3 (forkhead box P3) in whole aorta ( Supplementary Fig. 13d ).
To further investigate whether R. intestinalis impacted circulating metabolites, we performed metabolome analysis of plasma using ultrahigh-performance liquid chromatography-tandem mass spectroscopy (UPLC-MS/MS). A total of 678 metabolites were observed (Supplementary Fig. 14 and Supplementary Table 12 ), 88 of which were differentially represented between the 2 groups of animals (P < 0.05; for the purpose of generating hypotheses, all metabolites showing a P value < 0.05 were used for subsequent analyses). Enrichment analysis of differentially represented metabolites showed that long-chain fatty acid (LCFA), phosphatidylethanolamine, eicosanoids and branched chain amino acid metabolism were among the most regulated pathways (Supplementary Table 13 ). Levels of all 14 detected LCFAs were lower in mice colonized with R. intestinalis, 9 of which were significantly diminished (P < 0.05; Fig. 4e and Supplementary Table 12 ). This is in line with previous work showing that butyrate upregulates oxidation of fatty acids in liver tissue. Alternatively, the reduction in LCFAs in mice colonized with R. intestinalis could be due to decreased lipolysis, which can be inhibited by butyrate 33 .
Butyrate is known to upregulate ketogenesis in liver 34 . Consistent with this, the ketone body β -hydroxybutyrate was detected at higher levels in the 'core plus R. intestinalis' colonized mice (P = 0.002, q < 0.10; Fig. 4e ). β -hydroxybutyrate suppresses chronic inflammatory processes by inhibiting NLRP3 inflammasome-driven inflammatory responses 35 . There was also a reduction of all five eicosanoids detected in these mice; 12-hydroxyeicosatetraenoic acid (12-HETE) and 15-ketoeicosatetraenoic acid (15-KETE), which are 12/15-lipoxygenase products of arachidonic acid, were significantly lower (P < 0.05, Fig. 4e and Supplementary Table 12 ). Interestingly, it has been shown that LPS induces inflammatory activation of arachidonic acid signalling in macrophages 36 , which in turn promotes atherogenesis via production of IL-12 37 and/or oxidative modulation of low-density lipoprotein 38 . Furthermore, we found significant positive correlations between eicosanoids and LPS levels in plasma ( Supplementary  Fig. 15 ). In summary, our data suggest that R. intestinalis stimulates fatty acid oxidation in enterocytes, improves endotoxaemia, and results in the alteration of circulating eicosanoids, β -hydroxybutyrate and IL-12 and the amelioration of atherosclerosis.
Tributyrin supplementation reduces the development of atherosclerotic plaque formation. The data presented above suggest the athero-protective effect of R. intestinalis to be in part mediated by butyrate. To directly test this hypothesis, we conducted an experiment where tributyrin (TB), a triglyceride analogue of butyrate that is metabolized to butyrate by pancreatic lipases, was supplemented Table 14 ). Two groups of GF male ApoE −/− mice were orally gavaged with the 'core II' community, and were fed the HPP diet or a 6% TB-supplemented diet (Fig. 5a ). COPRO-Seq analysis showed that the TB treatment slightly increased the levels of B. caccae while it did not affect the abundance of other species in the community ( Fig. 5b and Supplementary Table 15 ). As expected, dietary TB supplementation resulted in a significant increase of caecal butyrate levels, although these were relatively low (~0.1 μ mol g −1 wt), suggesting that most of the butyrate derived from TB might be absorbed in the distal small intestine ( Supplementary Fig. 16a ). Supplementation of TB did not impact acetate or propionate levels in the caecum ( Supplementary Fig. 16a ) nor SCFAs in plasma ( Supplementary  Fig. 16b ). Importantly, we found that administration of TB significantly inhibited the development of atherosclerosis ( Fig. 5c,e ), lipid deposition ( Fig. 5c ,f) and macrophage accumulation ( Fig. 5d ,g) in the plaque while it did not change the levels of plasma lipid profile ( Supplementary Table 6 ), collagen ( Supplementary Fig. 17a ,c) or smooth muscle cells ( Supplementary Fig. 17b,d ) in the aortic sinus. Consistent with the results observed with R. intestinalis, TB supplementation did not affect levels of CD4 + T cells and Tregs in spleen or para-aortic lymph node samples ( Supplementary Fig. 18 ). Moreover, TB supplementation significantly reduced gut permeability as measured by the FITC-dextran assay as well as plasma LPS levels (Fig. 5h,i) . These results suggest that butyrate inhibits the development of atherosclerosis at least in part by reducing endotoxaemia and that butyrate mediates the vascular benefits associated with increased Roseburia colonization.
Discussion
A large body of literature supports the notion that consumption of dietary fibre decreases the risk of cardiometabolic disease 39 . Recent studies suggest that some of the benefits associated with consumption of dietary fibre are mediated in part by gut microbes 40 , with increased representation of butyrate-producing microbes proposed as one of the potential mediators 41 . Moreover, butyrate producers have been frequently found at higher levels in healthy populations relative to patients suffering various inflammatory and metabolic diseases 16, 18, 19 . Our study provides causal evidence linking increased abundance of butyrate-producing bacteria with: higher caecal levels of butyrate; epigenetic, transcriptional and metabolic changes in the intestine; decreased systemic markers of inflammation; and smaller atherosclerotic lesions. Previous work revealed that butyrate regulates generation of colonic Tregs through HDAC inhibition, and Tregs have been shown to inhibit atherosclerosis by dampening effector T-cell responses 32, 42 ; however, we did not observe any significant difference in Tregs in the aorta or in paraaortic lymph nodes, suggesting that, at least in our studies, the observed athero-protective effect seems to be independent of aortic Treg cells. The effects of butyrate-producing bacteria on atherosclerosis and inflammation could be linked to the metabolic effects that butyrate has in the intestine. Butyrate is efficiently absorbed and oxidized to acetyl-CoA in mitochondria, and represents the main fuel for normal colonocytes.
We found that introduction of R. intestinalis alters histone epigenetic states and modulates gene expression in the gut. The observed changes in gene expression suggest that the presence of the butyrate producer directed epithelial metabolism away from glycolysis and toward fatty acid utilization. Butyrate oxidation increases epithelial O 2 consumption and stabilization of hypoxia-inducible factor 43 , which in turn can enhance epithelial barrier function in vitro and in vivo 44 . This is consistent with our findings that the expression of several genes in mitochondrial fatty acid oxidation was significantly upregulated. While we did not observe evidence of transcriptionally regulated genes downstream of hypoxia-inducible factor, we cannot exclude possible involvement of this pathway. Butyrate can reach the liver via portal circulation, where it also stimulates β -oxidation and ketogenesis 34 . Untargeted mass spectrometry suggested that R. intestinalis-dependent increase in butyrate stimulates oxidation of LCFAs and production of ketone bodies. The increase in the ketone body β -hydroxybutyrate may contribute to the protective effect of R. intestinalis, as this metabolite has been shown to inhibit key inflammatory pathways involved in atherosclerosis. An additional mechanism by which R. intestinalis impacts the host relates to the effects of butyrate on chromatin, as butyrate is a HDAC inhibitor 45 . However, the presence of R. intestinalis and a dramatic increase in butyrate levels did not result in extensive changes of colonic histone acetylation, apart from a modest increase in H3K18/K23 acetylation. In contrast, we observed larger effects on histone methylation that predict an active chromatin state. Given the combinatorial nature of histone modifications, it is possible that HDAC inhibition can also impact histone methylation. Indeed, methylation of H3K4 has been shown to preferentially occur on acetylated histones in cultured cells treated with HDAC inhibitors 27 . Collectively, our findings suggest that R. intestinalis affects host histone methylation as well as acetylation, impacting gene expression in the colon. Although understanding the impact of these changes on histone PTM will require further analysis, we speculate that these observations may provide a mechanistic link between changes in nutrient availability (that is, butyrate) and the effects in gene expression related to energy metabolism caused by the introduction of the prominent butyrate producer.
In summary, we show that colonization with R. intestinalis lowers endotoxaemia, possibly by improving barrier function, and reduces inflammatory markers in plasma and aorta, and the extent of atherosclerotic lesion in a diet-dependent fashion. Our results suggest that the athero-protective effect of R. intestinalis is mediated at least in part by butyrate. Moreover, R. intestinalis may impact the host via different molecules through mechanisms not examined in this study. Future experiments using GF mice colonized with defined communities with different abundances of butyrate producers supplied with different types of dietary polysaccharide will inform synbiotic approaches for prevention and/or treatment of cardiovascular disease.
Methods
The Ath-HMDP studies. The animal work of the Ath-HMDP panel was conducted as previously described 22 . Briefly, mice carrying the human transgene for CETP in a C57BL/6 background were obtained from The Jackson Laboratory (stock number 003904). Mice carrying the human ApoE3 Leiden variant were kindly provided by L. Havekes. For the purposes of these experiments, we interbred these mice to create a strain carrying both transgenes and these were bred to females from ~100 common inbred and recombinant inbred strains purchased from The Jackson Laboratory. Male and female progeny were genotyped for the presence of both transgenes and, at the age of about 8 weeks, were placed on a 'Western style' synthetic high-fat diet (33 kcal% fat from cocoa butter) supplemented with 1% cholesterol (Research Diets D10042101, Supplementary Table 16 ). Mice from different strains and sex were housed in separate cages, but in the same room throughout the study. After 16 weeks on this diet, 147 male and 195 female mice (83 strains in total) were euthanized for collection of tissue. Euthanasia of mice was carried out using deep anaesthesia with isoflurane vapour followed by cervical dislocation. The animal work of the Ath-HMDP panel was conducted according to relevant national and international guidelines and was approved by the UCLA Animal Research Committee, the UCLA IACUC.
Sequencing of 16S rRNA genes. Caeca from a total of 195 female mice (71 strains) and 147 male mice (60 strains) were profiled for bacterial taxa using 16S rRNA gene sequencing. Microbial DNA was extracted using the PowerSoil DNA Isolation Kit (MO BIO Laboratories). Amplification and sequencing of the V4 hypervariable region of the 16S rRNA gene was performed using the validated, region-specific bacterial primers 515F and 806R. The reverse amplification primer contained a 12-base-pair (bp) Golay error-correcting barcode sequence and amplicons were generated in triplicate using 5 Prime Hot MasterMix (Fischer Scientific). The PCR conditions consisted of an initial denaturation step of 94 °C for 3 min; 35 cycles of 94 °C for 45 s, 50 °C for 30 s, and 72 °C for 90 s, followed by 72 °C for 5 min. Replicate amplicons were quantified with Quanti-iT PicoGreen dsDNA Assay Kit (Life Technologies Corporation), pooled (200 ng from 96 samples) and purified using with the UltraClean PCR Clean-up Kit (MOBIO Laboratories, Inc.). The purified, pooled PCR products were sequenced on a 454 pyrosequencing platform according to the Roche 454 recommended procedures. De-multiplexing 16S rRNA gene sequences, quality control and operational taxonomic unit binning were performed using the open source pipeline Quantitative Insights Into Microbial Ecology (QIIME) version 1.7.0. Quality-filtered reads were de-multiplexed, yielding an average length of 298 bases per read, and an average coverage of 2,510 sequences per sample. Sequences were binned into operational taxonomic units based on 97% identity using UCLUST against the Greengenes reference database. Each sample's sequences were rarefied to a depth of 200 reads to reduce the effect of sequencing depth. Microbial composition at each taxonomic level was defined using the summarize_taxa function in QIIME. The relative abundance of each taxon was calculated by dividing the sequences pertaining to a specific taxon by the total number of bacterial sequences for that sample.
Correlation analysis. The biweight midcorrelation statistic is analogous to the Pearson correlation coefficient, but has the advantage of being robust to outliers. We used the bicor function implemented in the WGCNA R package to calculate the microbiota-lesion size correlations in the Ath-HMDP panel.
Growth medium. All bacteria were grown on Mega Medium ( Supplementary  Table 17 ). This medium was filter-sterilized and stored in a Coy anaerobic chamber (5% H 2 , 20% CO 2 and 75% N 2 ) 46 .
Gnotobiotic husbandry. All experiments involving gnotobiotic mice were performed using protocols approved by the University of Wisconsin-Madison Animal Care and Use Committee. All GF C57BL/6 ApoE −/− mice were maintained in a controlled environment in plastic flexible film gnotobiotic isolators under a strict 12 h light/dark cycle and received sterilized water and standard chow (LabDiet 5021; LabDiet) ad libitum until 8 weeks of age. Sterility of GF animals was assessed by incubating freshly collected faecal samples under aerobic and anaerobic conditions using standard microbiology methods.
Gnotobiotic mouse colonization. Aliquots of each frozen bacterial strain were inoculated into 10 ml of Mega Medium and grown anaerobically at 37 °C overnight. Strains belonging to the same community were then combined in an equal volume ratio in a sterile and anaerobic Hungate tube. In the experiments shown in Fig. 1a and Supplementary Fig. 6a, 8 -week-old GF male mice were inoculated by oral gavage with 0.2 ml of mixed bacterial culture, 'core' community or 'core plus R. intestinalis' (Supplementary Table 3 ), in the gnotobiotic isolator. Mice were switched to a standard grain-based chow diet (Supplementary Table 20 ). Experimental diets were sterilized by irradiation. Mice were then euthanized at 26 weeks of age after 4 h fasting. In the experiment shown in Fig. 5a, 6 -week-old GF male mice were inoculated by oral gavage with 0.2 ml of mixed bacterial culture 'core II' ( Supplementary Table 14 ) in the gnotobiotic isolator. Mice were switched to a control chow diet ( Supplementary Table 18 , TD.2918) or a 6% TB-supplemented chow diet. The mice were then euthanized at 22 weeks of age after 4 h fasting.
A statement about the experimental design. We determined the mean sample variance in atherosclerosis lesion size (μ m 2 ) using data from our preliminary studies in gnotobiotic ApoE KO mice and found that using a minimum of 8 mice per group is necessary to detect atherosclerotic lesion changes of 20% or greater, assuming α = 0.05 and power = 0.80. In the atherosclerosis experiments shown in Figs. 2 and 5 and Supplementary Fig. 6 , we performed two sets of experiments using animals from different litters, and combined results in the figures. No randomization protocols or blinded analysis were employed.
Atherosclerotic lesion assessments.
Atherosclerotic lesions were assessed as previously described 12 . Briefly, mice were anaesthetized and the aorta was perfused with phosphate-buffered saline (PBS). To assess the atherosclerotic lesion size at the aortic sinus, the samples were cut in the ascending aorta, and the proximal samples containing the aortic sinus were embedded in OCT compounds (Tissue-Tek; Sakura Finetek). Five consecutive sections (10 μ m thickness) taken at 100 μ m intervals (that is, 50, 150, 250, 350 and 450 μ m from the bottom of the aortic sinus) were collected from each mouse and stained with Oil Red O. Plaque area and Oil Red O-positive area were measured using ImageJ software (National Institutes of Health). The volume of atherosclerosis in the aortic sinus was expressed as the mean size of the five sections for each mouse. Immunohistochemistry was performed on formalin-fixed cryosections of mouse aortic roots using antibodies to identify macrophages (MOMA-2, 1:50; ab33451, Abcam), followed by detection with biotinylated secondary antibodies (1:400; ab6733, Abcam) and streptavidinhorseradish peroxidase (1:500; P0397, Dako). Smooth muscle cells were identified by immunostaining with FITC-conjugated primary antibody against α -smooth muscle actin (1:100; clone 1A4, Sigma), followed by anti-FITC biotin-conjugated secondary antibody (1:400; clone FL-D6, Sigma). Negative controls were prepared by substitution with an isotype control antibody. Staining with Masson's trichrome was used to delineate the fibrous area according to the manufacturer's instructions (ab150686, Abcam). Stained sections were digitally captured, and the percentage of the stained area (the stained area per total atherosclerotic lesion area) was calculated.
COPRO-Seq analysis. Bacterial communities resulting from inoculation of GF animals were analysed using Illumina sequencing according to the COPRO-Seq method 47 . Faeces were collected 4 weeks after the colonization. In short, DNA isolated from faeces via bead beating was used to prepare libraries for shotgun Illumina sequencing. Five hundred nanograms of DNA from each sample was fragmented by sonication and subjected to enzymatic blunting and adenine tailing. Customized Illumina adapters containing maximally distant 8-bp bar codes were ligated to the poly (A)-tailed DNA. Gel-extracted DNA (size selection ~250 to 300 bp) was amplified by PCR using primers and cycling conditions recommended by Illumina. Purified PCR products were submitted to the UW-Madison Biotechnology Center for a single-end 50-bp Illumina MiSeq run. Results were processed using the software pipeline detailed by McNulty et al. 47 .
Plasma biochemical analysis. Blood samples were drawn by cardiac puncture under anaesthesia using isoflurane. Plasma was acquired by centrifugation and stored at − 80 °C until measurement. The levels of triglycerides, total cholesterol and high-density lipoprotein cholesterol were measured with commercially available kits from Wako Chemicals. Quantification of plasma cytokines was carried out using the Bio-plex 23 cytokine mouse array (Bio-Rad) as per the manufacturer's instructions. Cytokines profiled were: eotaxin, G-CSF, GM-CSF, IFN-γ , IL-1α , IL-1β , IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-17A, KC, MCP-1, MIP-1α , MIP-1β , RANTES, TNF-α . Plasma LPS levels were quantitated with the QCL-1000 Endpoint Chromogenic LAL Assay (Lonza). Intestinal permeability was assessed using the nonmetabolizable macromolecule FITC-dextran (4 kDA, Sigma). Mice were fasted overnight and gavaged with FITC-dextran (44 mg 100 g −1 body weight) 4 h before bleeding. The concentration of FITC-dextran in serum was quantified spectrophotofluorometrically.
GC-MS of SCFA measurement. Sample preparation was based on a previously described procedure 48 with some modifications. Caecal contents were weighed in 4 ml vials, then 10 μ l of a mixture of internal standards (20 mM each; acetic acid-D4, Sigma-Aldrich no. 233315; propionic acid-D6, Sigma-Aldrich no. 490644; and butyric acid-D7, CDN isotopes no. D-171) was subsequently added, followed by 20 μ l of 33% HCl and 1 ml diethyl ether and the vials were sealed with polytetrafluoroethylene-lined screw caps. For plasma samples, 50 μ l of each sample, 1.25 μ l of the internal standard mix, 5 μ l of 33% HCl and 0.75 ml of diethyl ether were mixed. The mixture was vortexed vigorously for 3 min and then centrifuged (4,000g, 10 min). The upper organic layer was transferred to another vial and a second diethyl ether extraction was performed. After combining the 2 ether extracts, a 60 μ l aliquot was removed, combined with 2 μ l N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (Sigma-Aldrich no. 394882) in a GC auto-sampler vial with a 200 μ l glass insert, and incubated for 2 h at room temperature. Derivatized samples (1 μ l) were injected onto an Agilent 7890B/5977A GC/MSD instrument with an Agilent DB1-ms 0.25 mm × 60 m column with a 0.25 μ m bonded phase. A discontinuous oven programme was used starting at 40 °C for 2.25 min, then ramping at 20 °C min −1 to 200 °C, then ramping at 100 °C min −1 to 300 °C and holding for 7 min. The total run time was 18.25 min. Linear column flow was maintained at 1.26 ml min −1 . The inlet temperature was set to 250 °C with an injection split ratio of 15:1. Quantification was performed using selected ion monitoring acquisition mode and metabolites were compared to relevant labelled internal standards using Agilent Mass Hunter v. Acquisition B.07.02.1938. The m/z values of monitored ions are as follows: 117 (acetic acid), 120 (acetic acid-D4), 131 (propionic acid), 136 (propionic acid-D6), 145 (butyric acid) and 152 (butyric acid-D7). Concentrations were normalized to milligrams of caecal contents.
Untargeted metabolome for plasma samples. Untargeted mass spectrometry data were collected at Metabolon Inc. Plasma samples were prepared using the automated MicroLab STAR system (Hamilton Company). To remove protein, dissociate small molecules bound to protein or trapped in the precipitated protein matrix, and to recover chemically diverse metabolites, proteins were precipitated with methanol under vigorous shaking for 2 min (Glen Mills GenoGrinder 2000) followed by centrifugation. The resulting extract was divided into five fractions: two for analysis by two separate reverse-phase UPLC-MS/MS methods with positive ion mode electrospray ionization (ESI), one for analysis by reverse-phase UPLC-MS/MS with negative ion mode ESI, one for analysis by HILIC/UPLC-MS/MS with negative ion mode ESI, and one sample was reserved for backup. Samples were placed briefly on a TurboVap (Zymark) to remove the organic solvent. The sample extracts were stored overnight under nitrogen before preparation for analysis.
UPLC-MS/MS. All methods utilized a Waters ACQUITY ultra-performance liquid chromatography system and a Thermo Scientific Q-Exactive high-resolution/ accurate mass spectrometer interfaced with a heated ESI (HESI-II) source and an Orbitrap mass analyser operated at 35,000 mass resolution. The sample extract was dried and then reconstituted in solvents compatible to each of the four methods. Each reconstitution solvent contained a series of standards at fixed concentrations to ensure injection and chromatographic consistency. One aliquot was analysed using acidic positive ion conditions, chromatographically optimized for more hydrophilic compounds. In this method, the extract was gradient eluted from a C18 column (Waters UPLC BEH C18-2.1 × 100 mm, 1.7 µ m) using water and methanol, containing 0.05% perfluoropentanoic acid and 0.1% formic acid. Another aliquot was also analysed using acidic positive ion conditions; however, it was chromatographically optimized for more hydrophobic compounds. In this method, the extract was gradient eluted from the same aforementioned C18 column using methanol, acetonitrile, water, 0.05% perfluoropentanoic acid and 0.01% formic acid and was operated at an overall higher organic content. Another aliquot was analysed using basic negative ion optimized conditions using a separate dedicated C18 column. The basic extracts were gradient eluted from the column using methanol and water, amended with 6.5 mM ammonium bicarbonate at pH 8. The fourth aliquot was analysed via negative ionization following elution from a HILIC column (Waters UPLC BEH Amide 2.1 × 150 mm, 1.7 µ m) using a gradient consisting of water and acetonitrile with 10 mM ammonium formate, pH 10.8. Compounds were identified by comparison to library entries based on retention time/index, mass to charge ratio (m/z) and chromatographic data, and peaks were quantified using area-under-the curve.
Statistical analysis. The data set comprises a total of 678 biochemicals. Metabolic profiles were quantified in terms of relative abundance and median scaled to 1. Following log transformation and imputation of missing values, if any, with the minimum observed value for each compound, Welch's two-sample t-test was used to identify biochemicals that differed significantly between experimental groups. An estimate of the FDR (q-value) is calculated to take into account the multiple comparisons that normally occur in metabolomic-based studies. Enrichment pathways were determined by completing pathway set enrichment analysis within MetaboLync pathway analysis software. For this analysis, all metabolites with P value < 0.05 were included. For individual pairwise comparison, pathway enrichment displays the number of experimentally regulated compounds relative to all detected compounds in a pathway, compared to the total number of experimentally regulated compounds relative to all detected compounds in the study ( Supplementary Table 13 ).
Histone PTM quantification with mass spectrometry. Tissue fraction, histone extraction and label-free chemical derivatization. Nuclear fractions were prepared from flash-frozen whole post-mortem colon and aorta tissues. In brief, 50 mg of tissue was homogenized on ice in hypotonic lysis buffer (10 mM Tris-HCl, 10 mM NaCl and 3 mM MgCl 2 ) with HDAC and protease inhibitors (1 mM sodium butyrate, 4 μ M trichostatin A, 100 μ M phenylmethylsulfonyl fluoride, 10 μ g ml −1 leupeptin and 10 μ g ml −1 aprotinin). Crude subcellular fractions were separated by differential centrifugation at 800g for 10 min at 4 °C. The crude nuclear pellet was then washed twice with ice-cold PBS before acid extraction. Histones were acid extracted as described previously 49 . Histone extract (5 μ g) was then subjected to a hybrid chemical derivatization method using propionic anhydride to label protein amino termini and all unmodified and monomethylated lysine residues, followed by trypsinization for 6 h at 37 °C, and derivatization of newly generated peptide N termini with phenylisocyanate. This chemical derivatization method protects all lysine residues from cleavage by trypsin, which cleaves carboxy-terminally to unmodified lysine and arginine residues, enabling consistent generation of histone peptides amenable to analysis by mass spectrometry. Derivatized histone extracts were then desalted using in-house C18 stage tips.
Nano-liquid chromatography and ESI MS/MS. For each sample, 0.3 μ g of derivatized histone peptides was injected onto a Dionex Ultimate3000 nanoflow HPLC with a Waters nanoAcquity UPLC C18 column (100 m × 150 mm, 3 m) online with a Thermo Fisher Q-Exactive mass spectrometer and eluted at 700 nl min −1 . The mobile phase consisted of water + 0.1% formic acid (A) and acetonitrile + 0.1% formic acid (B). Histone peptides were resolved with a 2-step linear gradient of 2% to 25% mobile phase B over 60 min followed by 25% to 40% mobile phase B over 15 min. Data were acquired using data-independent acquisition (DIA) mode. The mass spectrometer was operated with an MS1 scan at resolution = 35,000, automatic gain control target = 1 × 10 6 and scan range = 390-910 m/z, followed by a DIA scan with a loop count of 10. DIA settings were as follows: window size = 10 m/z, resolution = 17,500, automatic gain control target = 1 × 10 6 , DIA maximum fill time = AUTO and normalized collision energy = 30. For each cycle, 1 full MS1 scan was followed by 10 MS2 scans using an isolation window size of 10 m/z. Histone PTM quantification. The Thermo.raw files were imported into Skyline for quantitative analysis as previously described 49 . Briefly, all MS1 and MS2 peaks were matched to an in-house spectral library following import on the basis of retention times and the presence of appropriate transitions. All imported histone peptide MS1 peaks and their integration bounds were also manually verified using XCalibur Qual Browser (v2.2). Peak areas for all selected transitions were exported and precursor ion peak areas were combined for quantification. Exported peak area values from Skyline were normalized within peptide families to the total area before calculation of fold changes and statistics. All P values were generated using a Welch's t-test. Statistical significance was determined by P < 0.05.
RNA-seq analysis. RNA was extracted from frozen livers by TRIzol extraction and then further cleaned using the Qiagen RNeasy Mini Kit and quantified using a Nanodrop 2000 spectrophotometer. A single-end complementary DNA library was prepared using the Illumina TruSeq stranded mRNA Sample Preparation kit (RS-122-2101) according to the manufacturer's specifications. Samples were multiplexed, normalized and pooled before sequencing on a HiSeq2500 at the University of Wisconsin-Madison Biotechnology Center. Sequencing reads were processed and filtered using the FastX Toolkit. The first 10 bp of each read were removed to eliminate GC bias at the beginning of each read using the FastX Trimmer. The 6-bp Illumina adapter sequences were then clipped using the FastX Clipper and a quality filter was applied to all reads to eliminate any reads with a quality score < 30 as determined by the FastX Quality Filter. Reads were then aligned to the mm9 mouse reference genome constructed to include only annotated genes (NM_RefSeqs) by Bowtie2 alignment. Seed length was set to 28 and allowed 2 mismatches per seed. Gene expression was then calculated using RSEM with a forward probability of 0.0 (for stranded libraries). Differential expression was calculated using EBSeq with a FDR = 0.05. Differentially expressed genes were curated by hand for functional clustering analysis.
Quantitative real-time PCR. Total RNA was extracted from whole aorta with TRizol reagent (Invitrogen). SuperScript II Reverse Transcriptase with oligo (dT) primer (all from Invitrogen) was used to synthesize 20 μ l cDNA templates from 100 ng purified RNA. cDNA was diluted 2× before use and quantitative PCR reactions were prepared in a 10 μ l volume using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) and 400 nM specific primers targeting the gene of interest. Reactions were run on a CFX96 Real-Time PCR System (Bio-Rad). The primer sequences for amplification of each transcript are listed in Supplementary  Table 21 . Relative gene expression was calculated by the ∆ ∆ Ct method using β -actin as an internal control.
Flow cytometric analysis.
For analyses of immune cells by flow cytometry, splenocytes and paraaortic lymph node cells were isolated and stained in PBS containing 2% fetal calf serum. Flow cytometry analysis was performed using BD LSRFortessa (BD Biosciences) or an Attune NxT Flow Cytometer (Thermo Fisher Scientific) with FlowJo software (Tree Star). The antibodies used were as follows: anti-TCRβ (clone H57-597; Biolegend), anti-CD4 (cloneRM4-5; Biolegend), anti-Foxp3 (clone FJK-16s; eBioscience). Intracellular staining of Foxp3 was performed using the Foxp3 staining buffer set (eBioscience) according to the manufacturer's instructions. The fluorescent staining was performed after blocking the Fc receptor with the anti-CD16/CD32 antibody. Surface staining was performed according to standard procedures at a density of 1 × 10 6 cells per 50 μ l, and the volumes were scaled up accordingly.
Statistical analysis. The data were expressed as individual dots with mean ± s.e.m. or box-and-whisker plots where the centre line represents the median, the boxes extend to the 25th and 75th percentiles and the whiskers extend to the minimum and maximum values, and analysed using GraphPad Prism 6.0 (GraphPad Software) or R (3.4.1). Significant differences between two groups were evaluated by two-tailed unpaired Student's t-tests or two-tailed Welch's t-test. In multiple testing, FDRs were computed using the Benjamini-Hochberg procedure. The level of significance was set at P value < 0.05 or FDR value < 0.10. The statistical analysis for RNA-seq and untargeted metabolome analyses are described in each Methods section.
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Experimental design 1. Sample size
Describe how sample size was determined. We determined the mean sample variance in atherosclerosis lesion size (μm2) using data from our preliminary studies in gnotobiotic ApoE KO mice and found that using a minimum of 8 mice per group is necessary to detect atherosclerotic lesion changes of 20% or greater, assuming α=0.05 and power=0.80.
Data exclusions
Describe any data exclusions.
No data was excluded from the analysis.
Replication
Describe whether the experimental findings were reliably reproduced.
In atherosclerosis experiments shown in Fig.2, Fig.5 , and Supplementary Fig.6 , we performed two sets of experiments using animals from different litters, and showed the total result. In the other Figures, we reported technical replicates.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The mice we used in the study were born on the same days. And they were randomly allocated to experimental groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
In the processing of atherosclerotic lesions, a third person, who was a pathologist and did not know this experiment, performed the data collection. For in vitro experiments, blinding was impossible and there was no blinding.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
